Detalles de la búsqueda
1.
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients.
Curr Oncol Rep
; 25(10): 1141-1152, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37624550
2.
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group.
World J Urol
; 39(4): 1161-1170, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32591899
3.
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity.
Pharmacology
; 100(5-6): 261-268, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28797006
4.
Idiopathic intracranial hypertension: a possible complication in the natural history of advanced prostate cancer.
Int J Urol
; 21(3): 335-7, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24107135
5.
Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis.
Case Rep Oncol
; 17(1): 56-68, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38188482
6.
The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study.
Cells
; 13(5)2024 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38474332
7.
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study.
Elife
; 132024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38656229
8.
Gonadal Function in Male Patients With Metastatic Renal Cell Cancer Treated With Sunitinib.
In Vivo
; 37(1): 410-416, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36593059
9.
Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question.
Endocrine
; 78(3): 441-445, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35986139
10.
Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation.
Front Oncol
; 12: 937713, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35936689
11.
Effect of Degarelix Administration on Bone Health in Prostate Cancer Patients Without Bone Metastases. The Blade Study.
J Clin Endocrinol Metab
; 107(12): 3398-3407, 2022 11 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35971857
12.
Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the CDK4/6 Inhibitor Palbociclib.
Clin Genitourin Cancer
; 19(4): 316-324, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33676835
13.
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study.
Prostate Cancer Prostatic Dis
; 24(3): 852-859, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33723362
14.
Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer patients: A multicentre, randomised Phase III study by the Piemonte Oncology Network.
Eur J Cancer
; 155: 127-135, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34371442
15.
Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial.
Eur J Cancer
; 155: 56-63, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34358777
16.
When Less Is More: Specific Capture and Analysis of Tumor Exosomes in Plasma Increases the Sensitivity of Liquid Biopsy for Comprehensive Detection of Multiple Androgen Receptor Phenotypes in Advanced Prostate Cancer Patients.
Biomedicines
; 8(5)2020 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32455948
17.
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures.
Front Oncol
; 10: 1574, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33014806
18.
Testosterone serum levels and prostate cancer prognosis: the double face of Janus.
Future Oncol
; 10(7): 1113-5, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24947249
19.
Whole-body Diffusion-weighted Magnetic Resonance Imaging for Assessment of the Bone Response Rate in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Enzalutamide.
Eur Urol
; 2024 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38772788
20.
Recommendations for surveillance and follow-up of men with testicular germ cell tumors: a multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica.
Crit Rev Oncol Hematol
; 137: 154-164, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31014511